Bacillus anthracis: Difference between revisions
From IDWiki
Bacillus anthracis
mNo edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
* |
*Causes '''anthrax''' |
||
| ⚫ | |||
== Background == |
|||
| ⚫ | |||
=== Microbiology === |
|||
| ⚫ | |||
== Clinical Manifestations == |
|||
=== Cutaneous anthrax === |
|||
* Caused by inoculation of spores into soft tissue |
|||
* Incubation period of 2 to 5 days |
|||
* Lesion develops at site of inoculation, starting as erythemaous papule, then ulceration, then eschar |
|||
* May progress to sepsis |
|||
=== Pulmonary anthrax === |
|||
* Caused by inhalation of spores |
|||
* Also known as woolsorter's disease |
|||
* Start with malaise, fever, and nonproductive cough, followed by respiratory distress, severe pulmonary edema, and death |
|||
=== Gastrointestinal anthrax === |
|||
* Caused by ingestion of spores |
|||
* Infects oropharynx or abdomen |
|||
* Causes sepsis |
|||
| ⚫ | |||
[[Category:Gram-positive bacilli]] |
[[Category:Gram-positive bacilli]] |
||
Revision as of 00:48, 28 July 2020
- Causes anthrax
Background
Microbiology
- Gram-positive bacillus that is distinguished from other Bacillus species by being non-motile and non-hemolytic
Clinical Manifestations
Cutaneous anthrax
- Caused by inoculation of spores into soft tissue
- Incubation period of 2 to 5 days
- Lesion develops at site of inoculation, starting as erythemaous papule, then ulceration, then eschar
- May progress to sepsis
Pulmonary anthrax
- Caused by inhalation of spores
- Also known as woolsorter's disease
- Start with malaise, fever, and nonproductive cough, followed by respiratory distress, severe pulmonary edema, and death
Gastrointestinal anthrax
- Caused by ingestion of spores
- Infects oropharynx or abdomen
- Causes sepsis
References
- ^ Tucker Maxson, Thiphasone Kongphet-Tran, Thitipong Mongkolrattanothai, Tatiana Travis, Katherine Hendricks, Corinne Parker, Heather P McLaughlin, Julia Bugrysheva, Frank Ambrosio, Pierre Michel, Blake Cherney, Christine Lascols, David Sue. Systematic Review of In Vitro Antimicrobial Susceptibility Testing for Bacillus anthracis, 1947–2019. Clinical Infectious Diseases. 2022;75(Supplement_3):S373-S378. doi:10.1093/cid/ciac520.
